Ren Juan, Chu Yongli, Ma Hongbing, Zhang Yuelang, Zhang Xiaozhi, Zhao Dongli, Li Zongfang, Wang Jiansheng, Gao Yan-E, Xiao Lisha, Liu Rui, Qian Jiansheng, Liu Yan, Wei Hongxia, Jiang Shiwen
Cancer Center, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China, 710061.
Curr Pharm Des. 2014;20(11):1857-65. doi: 10.2174/13816128113199990529.
Epigenetic changes including DNA methylation, histone modifications, chromatin remodeling and microRNAs play critical roles in tumorigenesis and tumor development. Reversal of epigenetic changes sensitizes some tumor cells to radiation. DNMT-I enhances the response of tumor cells to radiotherapy. AZA demethylated promoters of genes related to ionizing radiation response, such as p16 and hMLH1. The genes expression of the p53, RASSF1, and DAPK gene families was increased by 5-aza-CdR, which induces G2-M phase arrest and increased apoptosis. HDAC-I has both anti-tumor activity and radiation sensitization activity. HDAC-I disrupts both DNA damage sensing and repair processes: HDAC-I disrupts the association between HDAC enzyme and DNA sensor proteins 53BP1 and ATM. HDAC-I changes the acetylation status of both proteins involved in homologous recombination (HR) repair pathway which include BRCA1, Rad51, and Rad50, and proteins involved in non-homologous end joining (NHEJ) repair pathway which include Ku70, and DNA-PK. HDACs are also implicated as essential components in the DNA repair process itself. Besides the radiosensitizing mechanism of intervention of DNA repair, other possible mechanisms including cell cycle redistribution, acetylation of Hsp90, increased apoptosis, and decreased survival signals are also suggested. Some miRNAs also regulate the radiosensitivity of tumor cells. Inhibition of miR-34 expression or function, downregulation of miR-155, upregulation of miR-18a, Overexpression let-7g or knocking down LIN28B, and ectopically overexpressed miR-10 in cells with low endogenous miR-101 level increase the response of cells to irradiation. For radiation-resistant cancer cells, miR-7 sensitizes the radiation for cells which activated EGFR-PI3K-AKT signaling pathway.
表观遗传变化,包括DNA甲基化、组蛋白修饰、染色质重塑和微小RNA,在肿瘤发生和肿瘤发展中起着关键作用。表观遗传变化的逆转使一些肿瘤细胞对辐射敏感。DNA甲基转移酶抑制剂(DNMT-I)增强肿瘤细胞对放疗的反应。5-氮杂胞苷(AZA)使与电离辐射反应相关的基因启动子去甲基化,如p16和hMLH1。5-氮杂-2'-脱氧胞苷(5-aza-CdR)可增加p53、RASSF1和DAPK基因家族的基因表达,诱导G2-M期阻滞并增加细胞凋亡。组蛋白去乙酰化酶抑制剂(HDAC-I)具有抗肿瘤活性和辐射增敏活性。HDAC-I破坏DNA损伤感知和修复过程:HDAC-I破坏HDAC酶与DNA传感器蛋白53BP1和ATM之间的关联。HDAC-I改变参与同源重组(HR)修复途径的蛋白质的乙酰化状态,这些蛋白质包括BRCA1、Rad51和Rad50,以及参与非同源末端连接(NHEJ)修复途径的蛋白质,这些蛋白质包括Ku70和DNA依赖蛋白激酶(DNA-PK)。HDACs也被认为是DNA修复过程本身的重要组成部分。除了干预DNA修复的放射增敏机制外,还提出了其他可能的机制,包括细胞周期重新分布、热休克蛋白90(Hsp90)的乙酰化、细胞凋亡增加和生存信号减少。一些微小RNA也调节肿瘤细胞的放射敏感性。抑制miR-34的表达或功能、下调miR-155、上调miR-18a、过表达let-7g或敲低LIN28B,以及在低内源性miR-101水平的细胞中异位过表达miR-10,可增加细胞对辐射的反应。对于耐辐射癌细胞,miR-7使激活表皮生长因子受体-磷脂酰肌醇-3激酶-蛋白激酶B(EGFR-PI3K-AKT)信号通路的细胞对辐射敏感。